{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:08:59Z","timestamp":1795028939802,"version":"4.10.2"},"reference-count":98,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n                  <jats:p>Placenta accreta spectrum, formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. The most favored hypothesis regarding the etiology of placenta accreta spectrum is that a defect of the endometrial\u2013myometrial interface leads to a failure of normal decidualization in the area of a uterine scar, which allows abnormally deep placental anchoring villi and trophoblast infiltration. Maternal morbidity and mortality can occur because of severe and sometimes life-threatening hemorrhage, which often requires blood transfusion. Although ultrasound evaluation is important, the absence of ultrasound findings does not preclude a diagnosis of placenta accreta spectrum; thus, clinical risk factors remain equally important as predictors of placenta accreta spectrum by ultrasound findings. There are several risk factors for placenta accreta spectrum. The most common is a previous cesarean delivery, with the incidence of placenta accreta spectrum increasing with the number of prior cesarean deliveries. Antenatal diagnosis of placenta accreta spectrum is highly desirable because outcomes are optimized when delivery occurs at a level III or IV maternal care facility before the onset of labor or bleeding and with avoidance of placental disruption. The most generally accepted approach to placenta accreta spectrum is cesarean hysterectomy with the placenta left in situ after delivery of the fetus (attempts at placental removal are associated with significant risk of hemorrhage). Optimal management involves a standardized approach with a comprehensive multidisciplinary care team accustomed to management of placenta accreta spectrum. In addition, established infrastructure and strong nursing leadership accustomed to managing high-level postpartum hemorrhage should be in place, and access to a blood bank capable of employing massive transfusion protocols should help guide decisions about delivery location.<\/jats:p>","DOI":"10.1097\/aog.0000000000002983","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T12:04:21Z","timestamp":1542888261000},"page":"e259-e275","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":481,"title":["Obstetric Care Consensus No. 7: Placenta Accreta Spectrum"],"prefix":"10.1097","volume":"132","member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ajog.2005.06.037","article-title":"Placenta previa-accreta: risk factors and complications","volume":"193","author":"Usta","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/AOG.0b013e3181ad9442","article-title":"The frequency and complication rates of hysterectomy accompanying cesarean delivery. Eunice Kennedy Shriver National Institutes of Health and Human Development Maternal-Fetal Medicine Units Network","volume":"114","author":"Shellhaas","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.AOG.0000460770.99574.9f","article-title":"Levels of maternal care. Obstetric Care Consensus No. 2. American College of Obstetricians and Gynecologists","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ajog.2004.12.074","article-title":"Abnormal placentation: twenty-year analysis","volume":"192","author":"Wu","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20261118","first-page":"31","article-title":"Placenta accreta: changing clinical aspects and outcome","volume":"56","author":"Read","year":"1980","journal-title":"Obstet Gynecol"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9378(97)70463-0","article-title":"Clinical risk factors for placenta previa-placenta accreta","volume":"177","author":"Miller","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3109\/14767058.2015.1034103","article-title":"Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011","volume":"29","author":"Mogos","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"219.e1","DOI":"10.1016\/j.ajog.2012.12.037","article-title":"Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births","volume":"208","author":"Eshkoli","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20261118","first-page":"799","article-title":"Risk factors for placenta accreta: a large prospective cohort","volume":"31","author":"Bowman","year":"2014","journal-title":"Am J Perinatol"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"262.e1","DOI":"10.1016\/j.ajog.2011.06.035","article-title":"Impact of multiple cesarean deliveries on maternal morbidity: a systematic review","volume":"205","author":"Marshall","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20261118","doi-asserted-by":"crossref","first-page":"873929","DOI":"10.1155\/2012\/873929","article-title":"Epidemiology, etiology, diagnosis, and management of placenta accreta","volume":"2012","author":"Garmi","year":"2012","journal-title":"Obstet Gynecol Int"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/AOG.0000000000002434","article-title":"Antecedents of abnormally invasive placenta in primiparous women: risk associated with gynecologic procedures","volume":"131","author":"Baldwin","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/01.AOG.0000219750.79480.84","article-title":"Maternal morbidity associated with multiple repeat cesarean deliveries. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network","volume":"107","author":"Silver","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R14-20261118","first-page":"266","article-title":"Placenta accreta is associated with elevated maternal serum alpha-fetoprotein","volume":"82","author":"Kupferminc","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R15-20261118","first-page":"693","article-title":"Placenta accreta\/percreta\/increta: a cause of elevated maternal serum alpha-fetoprotein","volume":"80","author":"Zelop","year":"1992","journal-title":"Obstet Gynecol"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/jp.2015.40","article-title":"Maternal serum markers, characteristics and morbidly adherent placenta in women with previa","volume":"35","author":"Lyell","year":"2015","journal-title":"J Perinatol"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/pd.4277","article-title":"Elevated first trimester PAPP--a is associated with increased risk of placenta accreta","volume":"34","author":"Desai","year":"2014","journal-title":"Prenat Diagn"},{"key":"R18-20261118","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.3109\/14767058.2016.1152576","article-title":"Can venous ProBNP levels predict placenta accreta?","volume":"29","author":"Ersoy","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R19-20261118","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.placenta.2014.07.007","article-title":"Maternal plasma levels of cell-free beta-HCG mRNA as a prenatal diagnostic indicator of placenta accrete","volume":"35","author":"Zhou","year":"2014","journal-title":"Placenta"},{"key":"R20-20261118","doi-asserted-by":"crossref","first-page":"e106140","DOI":"10.1371\/journal.pone.0106140","article-title":"Effects of maternal smoking on the placental expression of genes related to angiogenesis and apoptosis during the first trimester","volume":"9","author":"Kawashima","year":"2014","journal-title":"PLoS One"},{"key":"R21-20261118","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijgo.2009.11.013","article-title":"Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta","volume":"109","author":"El Behery","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"R22-20261118","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajog.2017.05.067","article-title":"Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging","volume":"218","author":"Jauniaux","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R23-20261118","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.placenta.2008.04.008","article-title":"Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast","volume":"29","author":"Tantbirojn","year":"2008","journal-title":"Placenta"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1471-0528.2008.02037.x","article-title":"Optimal management strategies for placenta accreta","volume":"116","author":"Eller","year":"2009","journal-title":"BJOG"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/AOG.0b013e3182051db2","article-title":"Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care","volume":"117","author":"Eller","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R26-20261118","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e3181c4f12a","article-title":"Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta","volume":"115","author":"Warshak","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"218.e1","DOI":"10.1016\/j.ajog.2014.08.019","article-title":"Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach","volume":"212","author":"Shamshirsaz","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.7863\/ultra.32.8.1345","article-title":"Prenatal diagnosis of placenta accreta: is sonography all we need?","volume":"32","author":"Berkley","year":"2013","journal-title":"J Ultrasound Med"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/1471-0528.12557","article-title":"The antenatal diagnosis of placenta accreta","volume":"121","author":"Comstock","year":"2014","journal-title":"BJOG"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/uog.13194","article-title":"Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis","volume":"42","author":"D'Antonio","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.7863\/ultra.33.12.2153","article-title":"Interobserver variability of sonography for prediction of placenta accreta","volume":"33","author":"Bowman","year":"2014","journal-title":"J Ultrasound Med"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/uog.14952","article-title":"Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). European Working Group on Abnormally Invasive Placenta, (EW-AIP)","volume":"47","author":"Collins","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R33-20261118","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/1471-0528.13981","article-title":"Methods to induce labour: a systematic review, network meta-analysis and cost-effectiveness analysis","volume":"123","author":"Alfirevic","year":"2016","journal-title":"BJOG"},{"key":"R34-20261118","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/1471-0528.13547","article-title":"Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries","volume":"123","author":"Thurn","year":"2016","journal-title":"BJOG"},{"key":"R35-20261118","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/uog.13426","article-title":"Cesarean scar pregnancy is a precursor of morbidly adherent placenta","volume":"44","author":"Timor-Tritsch","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R36-20261118","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.14775","article-title":"Natural history of early first-trimester pregnancies implanted in Cesarean scars","volume":"46","author":"Zosmer","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R37-20261118","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.AOG.0000136084.92846.95","article-title":"Perinatal outcome of pregnancies complicated by placenta accreta","volume":"104","author":"Gielchinsky","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R38-20261118","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/uog.8827","article-title":"Diagnosis and morbidity of placenta accreta","volume":"37","author":"Esakoff","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R39-20261118","doi-asserted-by":"crossref","first-page":"618.e1","DOI":"10.1016\/j.ajog.2018.03.013","article-title":"Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders","volume":"218","author":"Einerson","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R40-20261118","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/jog.12469","article-title":"Lead and trace element levels in placenta, maternal and cord blood: a cross-sectional pilot study","volume":"40","author":"Reddy","year":"2014","journal-title":"J Obstet Gynaecol Res"},{"key":"R41-20261118","doi-asserted-by":"crossref","first-page":"e0149036","DOI":"10.1371\/journal.pone.0149036","article-title":"Serial change in cervical length for the prediction of emergency cesarean section in placenta previa","volume":"11","author":"Shin","year":"2016","journal-title":"PLoS One"},{"key":"R42-20261118","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/uog.6301","article-title":"Cervical length and risk of antepartum bleeding in women with complete placenta previa","volume":"33","author":"Ghi","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R43-20261118","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/AOG.0b013e3181ea2deb","article-title":"Ultrasonographic cervical length and risk of hemorrhage in pregnancies with placenta previa","volume":"116","author":"Stafford","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R44-20261118","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.7863\/ultra.16.05059","article-title":"Cervical length in patients at risk for placenta accreta","volume":"36","author":"Rac","year":"2017","journal-title":"J Ultrasound Med"},{"key":"R45-20261118","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ajog.2014.11.018","article-title":"Center of excellence for placenta accreta","volume":"212","author":"Silver","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R46-20261118","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ogc.2015.01.014","article-title":"Placenta accreta spectrum: accreta, increta, and percreta","volume":"42","author":"Silver","year":"2015","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R47-20261118","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/AOG.0b013e3181df94e8","article-title":"Regionalization of care for obstetric hemorrhage and its effect on maternal mortality","volume":"115","author":"Wright","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R48-20261118","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.AOG.0000431056.79334.cc","article-title":"Second-trimester abortion. Practice Bulletin No. 135. American College of Obstetricians and Gynecologists","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R49-20261118","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/AOG.0b013e3181f3588d","article-title":"Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta","volume":"116","author":"Robinson","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R50-20261118","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ajog.2010.09.013","article-title":"Placenta accreta. Publications Committee, Society for Maternal-Fetal Medicine","volume":"203","author":"Belfort","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R51-20261118","doi-asserted-by":"crossref","first-page":"38.e1","DOI":"10.1016\/j.ajog.2009.08.037","article-title":"Surgical management of placenta accreta: a cohort series and suggested approach","volume":"202","author":"Angstmann","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R52-20261118","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.10.019","article-title":"Society for Maternal-Fetal Medicine (SMFM) Consult Series #44: management of bleeding in the late preterm period. Society for Maternal-Fetal Medicine (SMFM)","volume":"218","author":"Gyamfi-Bannerman","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R53-20261118","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Antenatal corticosteroid therapy for fetal maturation. Committee Opinion No. 713. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R54-20261118","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajog.2017.02.016","article-title":"Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time","volume":"216","author":"Shamshirsaz","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R55-20261118","first-page":"353","article-title":"Hypogastric artery ligation for obstetric hemorrhage","volume":"66","author":"Clark","year":"1985","journal-title":"Obstet Gynecol"},{"key":"R56-20261118","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/ALN.0000000000000935","article-title":"Practice guidelines for obstetric anesthesia: an updated report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia and the Society for Obstetric Anesthesia and Perinatology","volume":"124","year":"2016","journal-title":"Anesthesiology"},{"key":"R57-20261118","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/AOG.0000000000002442","article-title":"Outcomes of planned compared with urgent deliveries using a multidisciplinary team approach for morbidly adherent placenta","volume":"131","author":"Shamshirsaz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R58-20261118","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1055\/s-0036-1584148","article-title":"Goes BY, et al. Predictors for emergency cesarean delivery in women with placenta previa","volume":"33","author":"Ruiter","year":"2016","journal-title":"Am J Perinatol"},{"key":"R59-20261118","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejogrb.2015.10.015","article-title":"A score to predict the risk of emergency caesarean delivery in women with antepartum bleeding and placenta praevia","volume":"195","author":"Pivano","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R60-20261118","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00270-005-0023-2","article-title":"Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta\/percreta","volume":"29","author":"Bodner","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R61-20261118","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ajog.2005.08.033","article-title":"Temporary balloon occlusion of the common iliac artery: new approach to bleeding control during cesarean hysterectomy for placenta percreta","volume":"193","author":"Shih","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R62-20261118","doi-asserted-by":"crossref","first-page":"470.e1","DOI":"10.1016\/j.ajog.2007.05.017","article-title":"Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation: a cautionary case","volume":"197","author":"Greenberg","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R63-20261118","doi-asserted-by":"crossref","first-page":"216.e1","DOI":"10.1016\/j.ajog.2012.06.007","article-title":"Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: a management paradox","volume":"207","author":"Ballas","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R64-20261118","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejogrb.2014.05.007","article-title":"Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta","volume":"179","author":"Cali","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R65-20261118","doi-asserted-by":"crossref","first-page":"402.e1","DOI":"10.1016\/j.ajog.2007.08.001","article-title":"Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta","volume":"197","author":"Shrivastava","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R66-20261118","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/AOG.0000000000001113","article-title":"Precesarean prophylactic balloon catheters for suspected placenta accreta: a randomized controlled trial","volume":"126","author":"Salim","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R67-20261118","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijoa.2010.09.012","article-title":"Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta","volume":"20","author":"Bishop","year":"2011","journal-title":"Int J Obstet Anesth"},{"key":"R68-20261118","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/AOG.0b013e3182238c31","article-title":"Use of prophylactic antibiotics in labor and delivery. Practice Bulletin No. 120. American College of Obstetricians and Gynecologists","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R69-20261118","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1213\/ANE.0000000000002050","article-title":"A standardized approach for transfusion medicine support in patients with morbidly adherent placenta","volume":"125","author":"Panigrahi","year":"2017","journal-title":"Anesth Analg"},{"key":"R70-20261118","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1097\/AOG.0000000000002351","article-title":"Postpartum hemorrhage. Practice Bulletin No. 183. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R71-20261118","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0959-289X(99)80002-8","article-title":"Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section","volume":"8","author":"Catling","year":"1999","journal-title":"Int J Obstet Anesth"},{"key":"R72-20261118","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1213\/00000539-199710000-00021","article-title":"The ability of the Haemonetics 4 Cell Saver System to remove tissue factor from blood contaminated with amniotic fluid","volume":"85","author":"Bernstein","year":"1997","journal-title":"Anesth Analg"},{"key":"R73-20261118","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00000542-200006000-00008","article-title":"Amniotic fluid removal during cell salvage in the cesarean section patient","volume":"92","author":"Waters","year":"2000","journal-title":"Anesthesiology"},{"key":"R74-20261118","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. WOMAN Trial Collaborators","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"R75-20261118","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/AOG.0000000000002253","article-title":"Tranexamic acid for the management of obstetric hemorrhage","volume":"130","author":"Pacheco","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R76-20261118","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2214-109X(17)30428-X","article-title":"Updated WHO recommendation on intravenous tranexamic acid for the treatment of post-partum haemorrhage [commentary]","volume":"6","author":"Vogel","year":"2018","journal-title":"Lancet Glob Health"},{"key":"R77-20261118","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/aogs.12798","article-title":"Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials","volume":"95","author":"Simonazzi","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R78-20261118","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.ajkd.2015.11.022","article-title":"Renal cortical necrosis in postpartum hemorrhage: a case series","volume":"68","author":"Frimat","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"R79-20261118","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. PPH Study Group","volume":"5","author":"Charbit","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R80-20261118","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1213\/ANE.0b013e3181c039e6","article-title":"Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Australian and New Zealand Haemostasis Registry","volume":"109","author":"Phillips","year":"2009","journal-title":"Anesth Analg"},{"key":"R81-20261118","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2014-04-567891","article-title":"Fibrin-based clot formation as an early and rapid biomarker for progression of postpartum hemorrhage: a prospective study","volume":"124","author":"Collins","year":"2014","journal-title":"Blood"},{"key":"R83-20261118","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ajog.2015.04.034","article-title":"Conservative management of morbidly adherent placenta: expert review","volume":"213","author":"Fox","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R84-20261118","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/1471-0528.12524","article-title":"Surgical management of placenta accreta: to leave or remove the placenta?","volume":"121","author":"Perez-Delboy","year":"2014","journal-title":"BJOG"},{"key":"R85-20261118","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.0001-6349.2004.00517.x","article-title":"Anterior placenta percreta: surgical approach, hemostasis and uterine repair","volume":"83","author":"Palacios Jaraquemada","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R86-20261118","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/01443615.2017.1340440","article-title":"Comparison of results of Bakri balloon tamponade and caesarean hysterectomy in management of placenta accreta and increta: a retrospective study","volume":"38","author":"Pala","year":"2018","journal-title":"J Obstet Gynaecol"},{"key":"R87-20261118","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/AOG.0b013e3181d066d4","article-title":"Maternal outcome after conservative treatment of placenta accreta","volume":"115","author":"Sentilhes","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R88-20261118","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2005.08.015","article-title":"Value of laparoscopic assistance for vaginal hysterectomy with prophylactic bilateral oophorectomy","volume":"194","author":"Agostini","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R89-20261118","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.AOG.0000136086.78099.0f","article-title":"Conservative versus extirpative management in cases of placenta accreta","volume":"104","author":"Kayem","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R90-20261118","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/ajo.12149","article-title":"Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature","volume":"54","author":"Pather","year":"2014","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R91-20261118","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/aogs.12079","article-title":"Conservative management of abnormally invasive placenta: four case reports","volume":"92","author":"Ramoni","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R92-20261118","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jmig.2014.04.004","article-title":"Conservative management of placenta accreta: hysteroscopic resection of retained tissues","volume":"21","author":"Legendre","year":"2014","journal-title":"J Minim Invasive Gynecol"},{"issue":"suppl 3","key":"R93-20261118","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/1471-0528.14743","article-title":"High-intensity focused ultrasound combined with hysteroscopic resection for the treatment of placenta accreta","volume":"124","author":"Ye","year":"2017","journal-title":"BJOG"},{"key":"R94-20261118","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/aogs.12295","article-title":"Management of placenta percreta: a review of published cases","volume":"93","author":"Clausen","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R95-20261118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40661-017-0049-6","article-title":"Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes","volume":"4","author":"Lee","year":"2017","journal-title":"Gynecol Oncol Res Pract"},{"key":"R96-20261118","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1111\/j.1537-2995.2011.03205.x","article-title":"Transfusion requirements in obstetric patients with placenta accreta","volume":"51","author":"Stotler","year":"2011","journal-title":"Transfusion"},{"key":"R97-20261118","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1447-0756.2007.00619.x","article-title":"Placenta previa increta\/percreta in Japan: a retrospective study of ultrasound findings, management and clinical course","volume":"33","author":"Sumigama","year":"2007","journal-title":"J Obstet Gynaecol Res"},{"key":"R98-20261118","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/humrep\/deq239","article-title":"Fertility and pregnancy outcomes following conservative treatment for placenta accreta","volume":"25","author":"Sentilhes","year":"2010","journal-title":"Hum Reprod"},{"key":"R99-20261118","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijgo.2014.05.013","article-title":"Outcomes of subsequent pregnancies after conservative treatment for placenta accreta","volume":"127","author":"Kabiri","year":"2014","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201812000-00050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:01:47Z","timestamp":1795024907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201812000-00050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002983","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]}}}